Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Gefapixant

Gefapixant

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Gefapixant

15 trials tracked of Gefapixant: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 306 citations.

15Trials tracked
4Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 4 Phase 2 9 Phase 1 2
  1. Phase 3 A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027) Completed · 306 cited
  2. Phase 3 Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043) Completed · 37 cited
  3. Phase 3 A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038) Completed · 14 cited
  4. Phase 3 Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042) Completed · 9 cited
  5. Phase 2 A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) Completed
  6. Phase 2 A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006) Completed
Show 9 more trials
  1. Phase 2 A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012) Completed
  2. Phase 2 A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010) Completed
  3. Phase 2 A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the Knee Completed
  4. Phase 2 An 8-Week Refractory Chronic Cough Study (MK-7264-021) Completed
  5. Phase 2 A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034) Completed
  6. Phase 2 Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015) Completed
  7. Phase 2 A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Completed
  8. Phase 1 Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039) Completed
  9. Phase 1 The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026) Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.